If you must get the CV19 jab but you really don’t want to:

FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, October 18, 2021

Canceling the Spike Protein
Striking Visual Evidence

Editorial by Thomas E. Levy, MD, JD

Link:  http://orthomolecular.org/resources/omns/v17n24.shtml 

The punch line (less than 50%):

Suggested Protocol (to be coordinated with the guidance of your chosen health care provider):

1. For individuals who are post-vaccination or symptomatic with chronic COVID, vitamin C should be optimally dosed, and it should be kept at a high but lesser dose daily indefinitely.
   • Ideally, an initial intravenous administration of 25 to 75 grams of vitamin C should be given depending on body size. Although one infusion would likely resolve the symptoms and abnormal blood examination, several more infusions can be given if feasible over the next few days.
   • An option that would likely prove to be sufficient and would be much more readily available to larger numbers of patients would be one or more rounds of vitamin C given as a 7.5 gram IV push over roughly 10 minutes, avoiding the need for a complete intravenous infusion setup, a prolonged time in a clinic, and substantially greater expense (Riordan-Clinic-IVC-Push-Protocol, 10.16.14.pdf).
   • Additionally, or alternatively if IV is not available, 5 grams of liposome-encapsulated vitamin C (LivOn Labs) can be given daily for at least a week.
   • When none of the above three options are readily available, a comparable positive clinical impact will be seen with the proper supplementation of regular forms of oral vitamin C as sodium ascorbate or ascorbic acid. Either of these can be taken daily in three divided doses approaching bowel tolerance after the individual determines their own unique needs (additional information, see Levy, vitamin C Guide in References; Cathcart, 1981).
   • An excellent way to support any or all of the above measures for improving vitamin C levels in the body is now available and very beneficial clinically. A supplemental polyphenol that appears to help many to overcome the epigenetic defect preventing the internal synthesis of vitamin C in the liver can be taken once daily. This supplement also appears to provide the individual with the ability to produce and release even greater amounts of vitamin C directly into the blood in the face of infection and other sources of oxidative stress (www.formula216.com).
2. Hydrogen peroxide (HP) nebulization (Levy, 2021, free eBook) is an antiviral and synergistic partner with vitamin C, and it is especially important in dealing with acute or chronic COVID, or with post-COVID vaccination issues. As noted above, the COVID virus can persist in the stool. In such cases, a chronic pathogen colonization (CPC) of COVID in the throat continually supplying virus that is swallowed into the gut is likely present as well, even when the patient seems to be clinically normal. This will commonly be the case when specific viral eradication measures were not taken during the clinical course of the COVID infection. HP nebulization will clear out this CPC, which will stop the continued seeding of the COVID virus in the gut and stool as well. Different nebulization approaches are discussed in the eBook.
3. When available, ozonated saline and/or ozone autohemotherapy infusions are excellent. Conceivably, this approach alone might suffice to knock out the spike protein presence, but the vitamin C and HP nebulization approaches will also improve and maintain health in general. Ultraviolet blood irradiation and hyperbaric oxygen therapy will likely achieve the same therapeutic effect if available.
4. Ivermectin, hydroxychloroquine, and chloroquine are especially important in preventing new binding of the spike protein to the ACE2 receptors that need to be bound in order for either the spike protein alone or for the entire virus to gain entry into the target cells (Lehrer and Rheinstein, 2020; Wang et al., 2020; Eweas et al., 2021). These agents also appear to have the ability to directly bind up any circulating spike protein before it binds any ACE2 receptors (Fantini et al., 2020; Sehailia and Chemat, 2020; Saha and Raihan, 2021). When the ACE2 receptors are already bound, the COVID virus cannot enter the cell (Pillay, 2020). These three agents also serve as ionophores that promote intracellular accumulation of zinc that is needed to kill/inactivate any intact virus particles that might still be present.
5. Many other positive nutrients, vitamins, and minerals are supportive of defeating the spike protein, but they should not be used to the exclusion of the above, especially the combination of highly-dosed vitamin C and HP nebulization.

—————————————————————————————————————————————————

Moving on.  How about the common herb, Danshen (cheap and does not taste bad):

Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2

Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013543/

“In conclusion, our study showed that SAA, SAB, and SAC inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2, suppressing the entry of 2019‐nCoV pseudovirus into ACE2h cells. Among these compounds, SAB showed the greatest binding affinity and anti‐2019‐nCoV pseudovirus effect; this provides new insights into the use of traditional Chinese medicine for the treatment and control of COVID‐19.”

In english: Component parts of Danshen inactivate the spike by binding to it and protect cells by bindind to ACE2 receptors.

—————————————————————————————————————————

More:

In this abstract there are many ACE2 inhibitors / Spike entry blocker molecules to choose from. Some are naturally occurring (no prescription needed).  Quite long but useful information:

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19

Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498772/ 

Fig 56:

Click on image to zoom (nih.gov)

You may have noticed Quercetin among the naturally occurring molecules. See this abstract:

Zinc 2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro

https://pubmed.ncbi.nlm.nih.gov/34514483/

Zinc deficiency is linked to poor prognosis in COVID-19 patients while clinical trials with zinc demonstrate better clinical outcomes. The molecular targets and mechanistic details of the anti-coronaviral activity of zinc remain obscure. We show that zinc not only inhibits the SARS-CoV-2 main protease (Mpro) with nanomolar affinity, but also viral replication. We present the first crystal structure of the Mpro-Zn2+ complex at 1.9 Å and provide the structural basis of viral replication inhibition. We show that Zn2+ coordinates with the catalytic dyad at the enzyme active site along with two previously unknown water molecules in a tetrahedral geometry to form a stable inhibited Mpro-Zn2+ complex. Further, the natural ionophore quercetin increases the anti-viral potency of Zn2+. As the catalytic dyad is highly conserved across SARS-CoV, MERS-CoV and all variants of SARS-CoV-2, Zn2+ mediated inhibition of Mpro may have wider implications.

In english: Zinc inhibits viral replication. Quercetin increases the effectiveness of zinc by helping it get into cells (ionophore).  And from the repurposed ACE2 inhibitor abstract, Quercetin blocks the spike.

Also did you notice Curcumin in the picture?  This is one of the active components of Turmeric (sure to spice up any meal).  Take this with Black Pepper, which contains Piperine. Piperine drastically increases the effectiveness of Curcumin (like 2000%).

See also:

Your Spice Rack VS Hydroxychloroquine

Link:  /health/2021/11/your-spice-rack-vs-hydroxychloroquine-3042858.html